We must not be surprised when politicians engage in hyperbole. For better or worse, it is a staple of political rhetoric--everything they do is "the best" and everything their opponents do is "the worst". This has been true of politics dating back to the Roman Republic.
We can therefore be reasonably skeptical when President Trump's Press Secretary, Kayleigh McEnany, describes FDA authorization of Convalescent Blood Plasma as a "breakthrough". We should expect such hyperbole for every bit of good news coming from any President's administration.
We should be far less forgiving, however, of the legacy media treating the hyperbole with a strange naivete, especially when choosing to downplay both the announcement and the significance of the treatment option. Convelscent Blood Plasma may be many things, but what no treatment that has been around for nearly 160 years can be called is a "breakthrough"--and it beggars belief that the legacy media remains studiously unaware of this fact.
